Biogen (BIIB) Stock Forecast for 2023 – 2026. Sell or Buy Prediction

Biogen (BIIB) Stock Forecast for 2023 – 2026. Sell or Buy?

Updated: December 6, 2023 (05:55)

Sector: Healthcare

The share price of Biogen Inc. (BIIB) now

Latest session on the 5th of December for
Biogen Inc. is negative
Trading Volume: 861300
Open: 232 /  High: 232.48 /  Low: 229.16
What analysts predict: $323.48
52-week High/Low: $319.76 / $220.86

50/200 Day Moving Average: $245.66 / $271.84

This figure corresponds to the Average Price over the previous 50/200 days. For Biogen stocks, the 50-day moving average is the resistance level today.

For Biogen stocks, the 200-day moving average is the resistance level today.

Are you interested in Biogen Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Biogen stock price in 2024, 2025, 2026, 2027, 2028. How much will one Biogen share be worth in 2024 - 2028?

When should I take profit in Biogen stock? When should I record a loss on Biogen stock? What are analysts' forecasts for Biogen stock? What is the future of Biogen stock? We forecast Biogen stock performance using neural networks based on historical data on Biogen stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Biogen stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Biogen shares. This happens once a day.




Historical and forecast chart of Biogen stock

The chart below shows the historical price of Biogen stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Biogen stock price can be found in the table below.

Long-term forecasts by years.

Biogen is an international biotechnology company that discovers, develops and provides drugs for the treatment of multiple sclerosis (MS) and other hematological, neurodegenerative, autoimmune and other diseases to patients around the world. Biogen is at the forefront of new drug research for neurological diseases and rare genetic diseases.

The company was founded in Geneva (Switzerland) in 1978 by several renowned and forward-thinking biologists. Later one of the founders, Ph.D. Walter Gilbert, received the Nobel Prize in Chemistry for the DNA sequencing method. And in 1993, another founder, Phillip Sharp, received the Nobel Prize in Physiology or Medicine for discovering and showing that the genes of higher organisms have a “discontinuous” structure.

Official site of the company

Biogen daily forecast for a month

Date Target Pes. Opt. Vol., %
Dec 08 225.38 220.04 229.04 4.09
Dec 09 224.37 221.95 228.81 3.09
Dec 10 217.64 213.00 218.95 2.79
Dec 11 216.40 213.80 220.88 3.31
Dec 12 221.92 219.92 225.05 2.33
Dec 13 225.05 220.12 227.88 3.53
Dec 14 225.25 222.95 227.48 2.03
Dec 15 222.55 221.14 226.82 2.57
Dec 16 222.68 220.47 226.69 2.82
Dec 17 220.21 216.51 224.17 3.54
Dec 18 219.75 215.20 223.30 3.77
Dec 19 220.54 218.62 223.78 2.36
Dec 20 222.92 220.98 225.59 2.09
Dec 21 226.86 223.60 231.97 3.74
Dec 22 231.36 228.02 234.41 2.80
Dec 23 235.17 231.93 239.97 3.47
Dec 24 238.56 233.76 242.14 3.58
Dec 25 244.07 240.70 248.76 3.35
Dec 26 246.49 241.09 249.37 3.44
Dec 27 239.24 234.36 241.75 3.15
Dec 28 236.15 232.12 240.19 3.48
Dec 29 232.75 230.73 237.50 2.94
Dec 30 239.25 234.51 242.69 3.49
Dec 31 238.53 233.09 241.25 3.50
Jan 01 245.61 242.15 250.70 3.53
Jan 02 249.44 247.35 252.06 1.91
Jan 03 251.32 247.32 252.90 2.26
Jan 04 245.43 243.37 250.22 2.81
Jan 05 242.34 236.67 244.31 3.23
Jan 06 241.91 240.02 243.43 1.42

Biogen Daily Price Targets


Biogen Stock Forecast 12-08-2023.

Forecast target price for 12-08-2023: $225.38.
Negative dynamics for Biogen shares will prevail with possible volatility of 3.926%.
Pessimistic target level: 220.04
Optimistic target level: 229.04

Biogen Stock Forecast 12-09-2023.

Forecast target price for 12-09-2023: $224.37.
Negative dynamics for Biogen shares will prevail with possible volatility of 3.001%.
Pessimistic target level: 221.95
Optimistic target level: 228.81

Biogen Stock Forecast 12-10-2023.

Forecast target price for 12-10-2023: $217.64.
Negative dynamics for Biogen shares will prevail with possible volatility of 2.714%.
Pessimistic target level: 213.00
Optimistic target level: 218.95

Biogen Stock Forecast 12-11-2023.

Forecast target price for 12-11-2023: $216.40.
Negative dynamics for Biogen shares will prevail with possible volatility of 3.204%.
Pessimistic target level: 213.80
Optimistic target level: 220.88

Biogen Stock Forecast 12-12-2023.

Forecast target price for 12-12-2023: $221.92.
Positive dynamics for Biogen shares will prevail with possible volatility of 2.278%.
Pessimistic target level: 219.92
Optimistic target level: 225.05

Biogen Stock Forecast 12-13-2023.

Forecast target price for 12-13-2023: $225.05.
Positive dynamics for Biogen shares will prevail with possible volatility of 3.407%.
Pessimistic target level: 220.12
Optimistic target level: 227.88

BIIB (BIIB) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan. 236.32 223.66 248.23 9.90
Feb. 242.77 230.28 255.26 9.79
Mar. 244.05 224.83 256.35 12.30
Apr. 238.66 230.14 244.18 5.75
May. 230.14 222.41 237.64 6.41
Jun. 250.68 238.84 269.37 11.34
Jul. 252.26 237.17 262.59 9.68
Aug. 250.94 238.29 262.80 9.32
Sep. 258.32 248.01 267.81 7.39
Oct. 255.06 234.98 274.08 14.27
Nov. 245.15 236.40 250.30 5.55
Dec. 223.53 215.08 235.03 8.49

Biogen forecast for this year


Biogen Stock Prediction for Jan 2024

An uptrend is forecast for this month with an optimal target price of $236.319. Pessimistic: $223.66. Optimistic: $248.23


Biogen Stock Prediction for Feb 2024

An uptrend is forecast for this month with an optimal target price of $242.771. Pessimistic: $230.28. Optimistic: $255.26


Biogen Stock Prediction for Mar 2024

An uptrend is forecast for this month with an optimal target price of $244.045. Pessimistic: $224.83. Optimistic: $256.35


Biogen Stock Prediction for Apr 2024

An downtrend is forecast for this month with an optimal target price of $238.664. Pessimistic: $230.14. Optimistic: $244.18


Biogen Stock Prediction for May 2024

An downtrend is forecast for this month with an optimal target price of $230.144. Pessimistic: $222.41. Optimistic: $237.64


Biogen Stock Prediction for Jun 2024

An uptrend is forecast for this month with an optimal target price of $250.684. Pessimistic: $238.84. Optimistic: $269.37


Biogen Stock Prediction for Jul 2024

An uptrend is forecast for this month with an optimal target price of $252.264. Pessimistic: $237.17. Optimistic: $262.59


Biogen Stock Prediction for Aug 2024

An downtrend is forecast for this month with an optimal target price of $250.939. Pessimistic: $238.29. Optimistic: $262.80


Biogen Stock Prediction for Sep 2024

An uptrend is forecast for this month with an optimal target price of $258.317. Pessimistic: $248.01. Optimistic: $267.81


Biogen Stock Prediction for Oct 2024

An downtrend is forecast for this month with an optimal target price of $255.062. Pessimistic: $234.98. Optimistic: $274.08


Biogen Stock Prediction for Nov 2024

An downtrend is forecast for this month with an optimal target price of $245.153. Pessimistic: $236.40. Optimistic: $250.30


Biogen Stock Prediction for Dec 2024

An downtrend is forecast for this month with an optimal target price of $223.53. Pessimistic: $215.08. Optimistic: $235.03



Biogen (BIIB) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 239.26 223.18 251.31 11.20
Feb 243.28 231.78 256.05 9.48
Mar 247.36 233.34 263.47 11.44
Apr 256.19 244.36 268.57 9.01
May 262.92 252.43 273.69 7.77
Jun 252.43 246.07 260.38 5.50
Jul 247.66 237.00 265.08 10.59
Aug 255.72 243.10 266.19 8.68
Sep 254.91 239.12 261.60 8.59
Oct 264.28 245.41 273.72 10.34
Nov 236.81 216.92 245.01 11.47
Dec 258.69 252.17 265.75 5.11

Biogen (BIIB) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 251.90 242.91 266.71 8.93
Feb 268.30 257.87 279.57 7.76
Mar 279.57 264.60 296.89 10.88
Apr 264.01 243.77 271.77 10.30
May 253.47 240.43 259.86 7.48
Jun 259.60 245.70 271.32 9.44
Jul 239.15 226.85 252.21 10.06
Aug 260.00 246.07 268.73 8.43
Sep 280.20 265.19 301.09 11.92
Oct 279.31 261.42 285.77 8.52
Nov 276.09 263.33 289.71 9.11
Dec 300.15 284.08 316.54 10.26

Biogen (BIIB) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 322.21 305.63 335.74 8.97
Feb 349.28 336.44 370.55 9.20
Mar 380.45 360.48 410.01 12.08
Apr 362.47 332.02 392.92 15.50
May 345.35 336.64 362.75 7.20
Jun 356.95 330.34 379.81 13.03
Jul 358.82 333.58 381.05 12.46
Aug 362.59 348.50 381.63 8.68
Sep 353.07 344.92 374.95 8.01
Oct 369.76 355.39 378.69 6.15
Nov 406.25 394.31 417.77 5.62
Dec 412.65 401.38 424.78 5.51

Biogen (BIIB) Monthly Stock Prediction for 2028

Month Target Pes. Opt. Vol., %
Jan 407.88 377.90 423.73 10.81
Feb 386.47 356.03 395.40 9.96
Mar 412.03 385.21 422.42 8.81
Apr 377.86 356.03 404.44 11.97
May 372.70 362.52 401.27 9.65
Jun 344.52 332.22 352.12 5.65
Jul 337.29 329.14 345.08 4.62
Aug 351.10 321.98 360.68 10.73
Sep 351.47 341.50 360.32 5.22
Oct 386.53 354.87 410.07 13.46
Nov 412.91 387.33 426.78 9.24
Dec 415.94 399.35 443.02 9.86

Biogen information and performance

Biogen Address

225 BINNEY STREET, CAMBRIDGE, MA, US

Market Capitalization: 33 739 500 000 $

Market capitalization of the Biogen Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of BIIB shares in the company outstanding by the market price of one share.

EBITDA: 2 536 600 000 $

EBITDA of Biogen is earnings before interest, income tax and depreciation of assets.

PE Ratio: 23.31

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: 6.24

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: 0.0371

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 9.99

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: -0.438
Quarterly Revenue Growth YOY: 0.009
Trailing PE: 23.31

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 14.31

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 3.946

Enterprise Value (EV) /Revenue

EV To EBITDA: 17.04

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 144898000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.